APA

Qaddoumi I., Kocak M., Pai Panandiker A. S., Armstrong G. T., Wetmore C., Crawford J. R., Lin T., Boyett J. M., Kun L. E., Boop F. A., Merchant T. E., Ellison D. W., Gajjar A. & Broniscer A. (20140418). Phase II Trial of Erlotinib during and after Radiotherapy in Children with Newly Diagnosed High-Grade Gliomas. : Frontiers in oncology.

Chicago

Qaddoumi Ibrahim, Kocak Mehmet, Pai Panandiker Atmaram S, Armstrong Gregory T, Wetmore Cynthia, Crawford John R, Lin Tong, Boyett James M, Kun Larry E, Boop Fredrick A, Merchant Thomas E, Ellison David W, Gajjar Amar and Broniscer Alberto. 20140418. Phase II Trial of Erlotinib during and after Radiotherapy in Children with Newly Diagnosed High-Grade Gliomas. : Frontiers in oncology.

Harvard

Qaddoumi I., Kocak M., Pai Panandiker A. S., Armstrong G. T., Wetmore C., Crawford J. R., Lin T., Boyett J. M., Kun L. E., Boop F. A., Merchant T. E., Ellison D. W., Gajjar A. and Broniscer A. (20140418). Phase II Trial of Erlotinib during and after Radiotherapy in Children with Newly Diagnosed High-Grade Gliomas. : Frontiers in oncology.

MLA

Qaddoumi Ibrahim, Kocak Mehmet, Pai Panandiker Atmaram S, Armstrong Gregory T, Wetmore Cynthia, Crawford John R, Lin Tong, Boyett James M, Kun Larry E, Boop Fredrick A, Merchant Thomas E, Ellison David W, Gajjar Amar and Broniscer Alberto. Phase II Trial of Erlotinib during and after Radiotherapy in Children with Newly Diagnosed High-Grade Gliomas. : Frontiers in oncology. 20140418.